Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Hardman Johnston International Equity. This analysis is provided for institutional research purposes only and is not investment advice.
"Strong Q3 performance driven by healthcare winners UCB and Sandoz, plus semiconductor recovery positioning. Defense and AI infrastructure themes supported by quality holdings."
Hardman Johnston's International Equity strategy delivered strong third quarter performance of 8.53% net, outperforming both MSCI EAFE and MSCI AC World ex US indices through positive stock selection. Healthcare and Consumer Discretionary were top sector contributors, led by UCB's successful Bimzelx data and Sandoz's biosimilar momentum, while Prosus benefited from AI-driven strategy and EU regulatory approval. The semiconductor holdings including TSMC and new position STMicroelectronics are positioned for cyclical recovery as the analog chip cycle appears to have troughed. Defense exposure through Rheinmetall and aerospace companies benefits from increased spending trends. Key risks include AI valuation concerns, tariff impacts, and macro-market disconnect with geopolitical tensions. The manager maintains constructive optimism over 3-5 years, emphasizing bottom-up opportunities in international markets where valuations remain attractive versus US peers. Portfolio positioning reflects confidence in individual stock selection despite macro uncertainties, with recent additions in semiconductors and electrical equipment supporting structural themes.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High conviction evident in detailed company-specific analysis, willingness to initiate new positions, and strong performance attribution. Manager demonstrates deep knowledge of holdings and clear investment rationale, though acknowledges macro uncertainties.
Growth Outlook
The manager acknowledges macro challenges including decelerating global growth, geopolitical tensions, and rising trade barriers, but expresses constructive optimism over a 3-5 year view. They see helpful tailwinds in some markets and themes with strong futures, balancing concerns with opportunities.
Risk Appetite
The portfolio maintains selective exposure with new positions initiated in semiconductors and electrical equipment. Cash levels are low at 1.5%, indicating willingness to deploy capital, but positioning appears measured rather than aggressive with focus on quality holdings.
Capital Deployment
Moderate deployment activity with two new positions initiated (STMicroelectronics and Prysmian) and two liquidated (Novo Nordisk and Atlassian). Cash remains low at 1.5%, suggesting selective but not aggressive deployment.
Forward Guidance
The manager expresses confidence in portfolio resilience and bottom-up opportunities while acknowledging macro uncertainties. They initiated new positions and maintain constructive views on key holdings, suggesting cautious optimism about future deployment.
Language Signal
Language includes positive terms like 'constructive optimism', 'attractive valuations', 'strong futures', and 'confident' balanced against concerns about 'disconnect', 'uncertainties', and 'risks'. Overall tone is cautiously positive with measured optimism.
Perceived Risk
Manager identifies multiple risk factors including AI valuation concerns, tariff impacts, macro-market disconnect, geopolitical tensions, and potential AI investment bubble. Acknowledges significant systemic risks while maintaining portfolio confidence.
Opportunity Density
Manager sees selective opportunities in international markets with attractive valuations versus US peers, semiconductor cycle recovery, and specific company situations. Opportunities appear targeted rather than broad-based.
Time Horizon
Clear emphasis on 3-5 year constructive optimism and long-term structural themes. Manager focuses on companies with medium-term growth opportunities and structural advantages, indicating patient capital approach.
